UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________
FORM 8-K
________________
CURRENT REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 22, 2004
ATHEROGENICS, INC.
(Exact Name of Registrant as Specified in its Charter)
|
Georgia |
0-31261 |
58-2108232 |
|
(State or other jurisdiction |
(Commission |
(I.R.S. Employer |
|
of incorporation) |
File Number) |
Identification Number) |
8995 Westside Parkway
Alpharetta, GA
30004
(Address of principal executive
offices)
Registrant's telephone number, including area code (678) 336-2500
_________________
Item 7. Financial Statements, Pro Forma
Financial Information and Exhibits
Exhibits.
The following exhibit is furnished as part of this current report on Form 8-K.
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
– |
Press Release dated July 22, 2004 |
|
|
|
|
Item 12. Results of Operations and
Financial Condition.
On July 22, 2004, AtheroGenics, Inc. issued a press release
to report the company’s financial results for the
quarter ended June 30, 2004. A copy of the press
release is attached to this current report on Form 8-K as
Exhibit 99.1.
____________________
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
ATHEROGENICS, INC. |
|
|
|
|
|
Date: July 22, 2004 |
|
/s/MARK P. COLONNESE___________ |
|
|
|
Mark P. Colonnese |
|
|
|
Senior Vice President of Finance and |
|
|
|
Administration and Chief Financial Officer |
____________________
3
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
– |
Press Release dated April 22, 2004 |
|
|
|
|
4